Feasibility and Efficacy of Virtual Reality Interventions to Improve Psychosocial Functioning in Psychosis: Systematic Review.
Alexandra H Schroeder, Bryce J M Bogie, Tabassum T Rahman...
https://pubmed.ncbi.nlm.nih.gov/35179501/Actively Recruiting
Led by The Royal Ottawa Mental Health Centre · Updated on 2026-04-16
52
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are evaluating a virtual reality cognitive remediation program designed for adults living with psychotic disorders such as schizophrenia and schizoaffective disorder. This program aims to improve thinking skills, social skills, and daily functioning in people who often face challenges in work, school, relationships, and independent living. The trial tests both the feasibility and effectiveness of this approach compared to an active control using virtual reality. Participants are randomly assigned to one of two groups a cognitive remediation intervention or an active control, both conducted in virtual reality. Each participant completes a 6-week training with 12 visits, during which they perform exercises in virtual reality sessions lasting about 15 minutes each, separated by breaks, followed by conversations with study staff. The study includes baseline assessments, post-intervention evaluations at one week and three months, and uses a smartphone app to monitor thinking skills and daily functioning at baseline, one week, and six months after the intervention. Throughout the study, participants complete clinical, neurocognitive, social-cognitive, and community functioning assessments during two baseline visits and follow-ups. They also fill out questionnaires about their experience after each training visit and a satisfaction survey one week after completing the program. Researchers measure the feasibility of the intervention through completion rates, symptoms of cybersickness, and acceptability. The study is closely monitored with various outcome measures including changes in cognitive and social functions, community participation, and real-time assessments using the smartphone app DigiSensing.
CONDITIONS
Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis
S
Synthia Guimond, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
The Royal Ottawa Mental Health Centre
Lead Sponsor
Fonds de la Recherche en Santé du Québec
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
2 baseline visits (in-person) for clinical, neurocognitive, social-cognitive, and community functioning assessments
Duration - 6 weeks
Participants complete a six-week training program with 12 visits. During each visit, participants engage in virtual reality exercises and have a conversation with study staff about a pre-selected topic. After each visit, participants complete short questionnaires about their experience.
12 visits (in-person), twice weekly
Duration - 3 months
Participants complete the same assessments as at baseline one week and three months after the intervention. At one week post-intervention, participants also complete a satisfaction questionnaire about the cognitive remediation program.
2 visits (in-person) at 1 week and 3 months post-intervention
Duration - 6 months
Participants complete ecological momentary assessments (EMAs) using a smartphone app at baseline, 1 week, and 6 months post-intervention to measure thinking skills and daily life functioning.
3 EMA assessments through smartphone app
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alexandra H Schroeder, Bryce J M Bogie, Tabassum T Rahman...
https://pubmed.ncbi.nlm.nih.gov/35179501/Cecelia Shvetz, Feng Gu, Jessica Drodge...
https://pubmed.ncbi.nlm.nih.gov/34934063/S Viertiö, A Tuulio-Henriksson, J Perälä...
https://pubmed.ncbi.nlm.nih.gov/21377336/Frida Simon Jahn, Marie Skovbye, Kia Obenhausen...
https://pubmed.ncbi.nlm.nih.gov/33857847/The Royal Ottawa Mental Health Centre
Lead Sponsor
Fonds de la Recherche en Santé du Québec
Collaborating Sponsor